Open AccessPrimary cervical cancer screening
Author(s) -
Víctor Manuel Vargas-Hernández,
Víctor Manuel Vargas-Aguilar,
José María Tovar-Rodríguez
Publication year - 2015
Publication title -
cirugía y cirujanos
Language(s) - English
Resource type - Journals
ISSN - 2444-0507
DOI - 10.1016/j.circen.2015.10.011
Subject(s) - medicine , cervical cancer , cytology , human papilloma virus , gynecology , human papillomavirus , cervical intraepithelial neoplasia , intraepithelial neoplasia , cancer , incidence (geometry) , false positive paradox , pathology , prostate cancer , physics , machine learning , computer science , optics
Cervicouterine cancer screening with cytology decreases incidence by more than 50%. The cause of this cancer is the human papilloma virus high risk, and requires a sensitive test to provide sufficient sensitivity and specificity for early detection and greater interval period when the results are negative. The test of the human papilloma virus high risk is effective and safe because of its excellent sensitivity, negative predictive value and optimal reproducibility, especially when combined with liquid-based cytology or biomarkers with viral load, with higher sensitivity and specificity, by reducing false positives for the detection of cervical intraepithelial neoplasia grade 2 or greater injury, with excellent clinical benefits to cervical cancer screening and related infection of human papilloma virus diseases, and is currently the best test for early detection infection of human papillomavirus and the risk of carcinogenesis